Clinical Trials

Showing trials with last updates posted in 2017.

NCT00764517 | COMPLETED | PHASE2
57 participants

Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia, or Relapsed B Cell Non-Hodgkin's Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2017-12-11
Start Date:
2008-08-31
Completion:
2015-01-31
Conditions
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • Recurrent Chronic Lymphocytic Leukemia
  • Recurrent Indolent Adult Non-Hodgkin Lymphoma
  • Refractory B-Cell Non-Hodgkin Lymphoma
Interventions
  • DRUG
  • OTHER
  • BIOLOGICAL
Previous
Sorted by latest updates
Next
Showing 40 trials per page